Featured Stories
Majority of Metal-on-Metal Hip Implant Failures Occur within Two Years, Study Finds

Majority of Metal-on-Metal Hip Implant Failures Occur within Two Years, Study Finds

A newly published metal-on-metal hip replacement study is reporting that the majority of failures occur early, within two years of surgery. The study, published in the journal Orthopedics, is just the latest to indicate that close follow-up of metal-on-metal hip implant patients is warranted.

Read More

Study Linking Z-Pak to Increased Death Risk Being Reviewed by FDA

Study Linking Z-Pak to Increased Death Risk Being Reviewed by FDA

The U.S. Food & Drug Administration (FDA) is reviewing a new study that reported an increased risk of sudden, heart-related deaths among people using the antibiotic Zithromax (azithromycin), known popularly as Z-Pak. In a statement issued late yesterday, the FDA said patients being treated with Zithromax should not stop taking ...

Read More

Canadian Warning Issued for Actos Bladder Cancer Side Effect Risk

Canadian Warning Issued for Actos Bladder Cancer Side Effect Risk

Health Canada has become the most recent national drug regulator to issue a warning about Actos and bladder cancer. Last month, the agency warned that interim results from a 10-year-study indicated that patients taking Actos for more than a year faced an increased risk of bladder cancer. Health Canada also ...

Read More

Pradaxa not Fit for a Dog, Family of Alleged Pradaxa Bleeding Victim Claims

Pradaxa not Fit for a Dog, Family of Alleged Pradaxa Bleeding Victim Claims

The family of a Texas woman who died just months before her 60th wedding anniversary believes she would be alive today were it not for Pradaxa (dabigatran). According to a report from the Houston Press, Pradaxa patient Loraine Franklin fell and hit her head last December, resulting in an intracranial ...

Read More

Estate of Kentucky Man Alleges Wrongful Death Due to Actos Bladder Cancer

Estate of Kentucky Man Alleges Wrongful Death Due to Actos Bladder Cancer

National law firm, Parker Waichman LLP, just filed a lawsuit on behalf of the estate of a Kentucky man who developed bladder cancer and subsequently died, allegedly due to the use of diabetes drug, Actos. The lawsuit names Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals USA, Inc., Takeda Pharmaceuticals North America, ...

Read More

Metal-on-Metal Hip Replacement Device

Smith & Nephew’s Birmingham Metal-on-Metal Hip Replacement Device

Wright Medical Inc. took steps in to 2006 to convince the U.S. Food & Drug Administration (FDA) to reject pre-market approval of rival Smith & Nephew’s Birmingham metal-on-metal hip implant. Wright Medical, which makes two metal-on-metal hip replacement devices, the Conserve and the Lieneage device, filed a citizen petition ...

Read More

Lawsuits over DePuy ASR Metal-on-Metal Hip Implants Continue to Mount

Lawsuits over DePuy ASR Metal-on-Metal Hip Implants Continue to Mount

DePuy Orthopaedics and its parent, Johnson & Johnson, continue to be hit with lawsuits over recalled metal-on-metal DePuy ASR hip implants. Just yesterday, the national law firm of Parker Waichman LLP announced it had filed yet another DePuy ASR hip implant lawsuit, this time on behalf of a Virginia resident ...

Read More

Stryker Metal Hip Implant Component Recall Bad News for Makers of Metal-on-Metal Hip Replacement Devices

Stryker Metal Hip Implant Component Recall Bad News for Makers of Metal-on-Metal Hip Replacement Devices

Stryker’s recent recall of two metal hip implant components, the Rejuvenate Modular and ABG II modular-neck hip stems, may have dealt a serious blow to one of the key arguments medical device manufacturers have made to defend their metal-on-metal hip replacements. Facing thousands of lawsuits, the makers of ...

Read More

FDA Gives 7 Companies Go Ahead To Market Generic Plavix

FDA Gives 7 Companies Go Ahead To Market Generic Plavix

The U.S. Food & Drug Administration (FDA) just gave seven companies the go-ahead to market generic Plavix. Plavix is a blood thinner prescribed for the prevention of blood clots, heart attacks, and which has been linked to serious side effects such as the heart attacks and strokes it is supposed to ...

Read More

Decision on Pradaxa Bleeding Lawsuit Multidistrict Litigation Expected Soon

Decision on Pradaxa Bleeding Lawsuit Multidistrict Litigation Expected Soon

Victims of alleged Pradaxa injuries are awaiting word on whether their lawsuits will be consolidated in a multidistrict litigation. According to a report from The Madison Record, so far just over two dozen Pradaxa bleeding lawsuits have been filed in federal courts throughout the U.S.

Read More

FDA Warns Hospira over Manufacturing Violations

The U.S. Food and Drug Administration (FDA) issued a warning letter to Hospira over manufacturing violations at an injectables plant in Australia. According to Wednesday securities filing, inspections in late February and early March revealed “significant violations” of drug manufactured protocols.

According to FiercaPharma, the agency found crystal particles in carboplatin injects. The FDA says Hospira failed to remedy the problem, and only warned doctors to inspect the chemotherapy drug months after the problem was noted. According to the FDA, Hospira has still not corrected this issue because the particles still appear in reserve samples. The letter says that the company failed to properly investigate failed batches and discrepancies between products. Continue reading

Posted in Legal News |

Eli Lilly Sued Over Marketing of Testosterone Drug

A suit filed in federal court in Newark, New Jersey claims that Eli Lilly failed to adequately warn of the risk of heart attacks and stroke with its testosterone replacement drug Axiron

Lilly markets Axiron to men by describing “symptoms” of “Low T,” such as decreased sexual desire, erectile dysfunction, fatigue and loss of energy, depressed mood, decreased strength and osteoporosis. But the lawsuit claims Low T is a “non-existent and unrecognized medical condition,” according to New Jersey Law Journal. The symptoms are often merely the result of increasing age or weight gain, according to court papers. Continue reading

Posted in Pharmaceuticals |

Potential Xolair Side Effects Include Serious Cardiac Injuries

Potential-Xolair-Side-Effects-Include-Serious-Cardiac-InjuriesHeart attack or cancer are two possible side effects of the asthma medication, Xolair (omalizumab). In fact, the U.S. Food and Drug Administration (FDA) is conducting an evaluation of interim safety findings concerning an ongoing study of the asthma medication. The study suggests increased risks of adverse cardiovascular and cerebrovascular events in some patients using Xolair. Genentech, a unit of Roche Holding AG, is the maker of Xolair, which is jointly marketed by Roche and Novartis AG. Continue reading

Posted in Pharmaceuticals |

Judge Rules Jurors in DePuy Hip Implant Trial Can Hear About Other Cases in Multidistrict Litigation

DePuy-Hip-ImplantOn Monday, a Texas federal judge allowed the plaintiff in a bellwether trial against Johnson & Johnson’s DePuy Orthopaedics unit to tell jurors about the 6,500 other cases pending in multidistrict litigation that allege injuries caused by defects in a metal-on-metal hip implant.

U.S. District Judge Ed Kinkeade said DePuy had opened the door to the mention of the other cases that target the Pinnacle hip implant by calling the plaintiff’s case an outlier and suggesting that the doctors who treated her were also outliers, Law360 reports. The judge said the plaintiff needed to be able to defend against that characterization. Continue reading

Posted in Defective Medical Devices, Depuy, Health Concerns, Metal Hip Implants, Recalled Medical Devices |

E-Cigarettes Carry Big Warning Labels

electronic-cigaretteElectronic cigarettes, or e-cigarettes carry warning labels cautioning users about the risks of nicotine. While this seems like a perfectly reasonable thing to do from a health perspective, The New York Times notes that these warnings are often more severe than the warnings on their combustible counterparts. Big Tobacco companies may have ulterior motives for placing more severe warning labels on e-cigarettes.

“Nicotine can increase your heart rate and blood pressure and cause dizziness, nausea, and stomach pain. Inhalation of this product may aggravate existing respiratory conditions. Ingestion of the non-vaporized concentrated ingredients in the cartridges can be poisonous.” part of the warning of MarkTen e-cigarettes reads. According to the Washington Post, the warnings on traditional combustible cigarettes typically carry a shorter warning mandated by the U.S. Food and Drug Administration (FDA). Continue reading

Posted in Legal News |

VCF Deadline Approaches for 9/11 Rescue Workers

VCF-Deadline-ApproachesDeadlines are approaching quickly for rescue workers and first responders who helped with the 9/11 recovery efforts and now suffer illnesses related to toxic dust exposure. For claimants that were diagnosed on or before October 12, 2012 with one of the cancers added to the list of eligible conditions on that date, the deadline to register with the Victim Compensation Fund (VCF) is October 12, 2014. Claimants who register are not required to file a claim for compensation at any time. Registering with the VCF simply preserves the right to file a claim in the future is necessary.

Claimants can file online, or submit a hard copy Eligibility Form. If neither of these is plausible, individuals can also fill out and submit an Interim Registration form; follow-up actions are needed if this form is used. Continue reading

Posted in Legal News |

Ford Recalls 850,000 Cars for Air Bag Flaw

Ford-Recalls-850000-CarsFord Motor Co. has announced the recall of 850,000 cars because of the risk of a short circuit that could prevent the air bags from deploying in a crash.

The recalled models include Ford C-Max, Fusion, Escape and Lincoln MKZ vehicles from model years 2013 and 2014. The company said the recall will cost $500 million, The Detroit News reports. The recall was prompted by an electrical glitch that could prevent the air bags from deploying in a crash. The restraints control module can short-circuit, Ford said. The company said if a short circuit occurs, the air bag warning indicator will illuminate. Depending on the location of the short circuit, the air bags, pretensioners, and side curtains may not function as intended, according to the News. It may also affect other systems that use data from the module, including stability control. Ford said it is not aware of any crashes or injuries related to the faulty module. Dealers will replace the module. Continue reading

Posted in Defective Products, Motor Vehicles, Product Recalls, Recalled Vehicles |

Male Enhancement Products Described as Dangerous

Male-Enhancement-Products-Described-as-DangerousFederal experts and physicians say that many male enhancement products may be deadly and the marketing used to tout these products is deceptive.

In fact, the U.S. Food and Drug Administration (FDA) has issued 20 public notifications in 2014 over tainted Internet products such as “Weekend Warrior” and “O.M.G.” that are sold with promises of male sexual enhancement. The FDA described the matter as “an emerging trend,” according to NBC News. Continue reading

Posted in Pharmaceuticals |

FDA: Cardiovascular and Cerebrovascular Risks with with Asthma Drug Xolair

Asthma-Drug-XolairAfter reviewing safety studies, the Food and Drug Administration (FDA) has found a slightly increased risk of problems involving blood vessels supplying the heart and brain in patients taking Xolair (omalizumab). The FDA has added information about these potential risks to the drug label.

According to the FDA Drug Safety Announcement, the heart and brain blood vessel problems included mini-strokes known as transient ischemic attacks or TIAs; heart attacks; sudden, unexpected chest pain; high blood pressure in the arteries of the lungs called pulmonary hypertension; and blood clots in the lungs and veins. Continue reading

Posted in Health Concerns, Pharmaceuticals |

NSAID Use Linked to Increased Risk of Venous Thromboembolism, Study Suggests

NSAID-Use-Linked-to-Increased-Risk-of-Venous-ThromboembolismUsing non-steroidal anti-inflammatory drugs (NSAIDs) can increase the risk of venous thromboembolism, according to a study published in the journal Rheumatology. The results of the study has important implications, considering the fact that NSAIDs are one of the most widely used medications around the world.

Venous thromboembolism is when a blood clot forms in a vein and subsequently breaks off, potentially getting lodged in another crucial blood vessel. Venous thromboembolism includes deep vein thrombosis (DVT), where a blood clot forms in the deep veins of the leg, and pulmonary embolism, a potentially life-threatening condition where the blood clot gets stuck in the lungs. Continue reading

Posted in Legal News |

© 2005-2014 Parker Waichman LLP ®. All Rights Reserved.